Monopar Therapeutics Inc. Information
Contact top employees from
Monopar Therapeutics Inc.
Summary
Monopar Therapeutics Inc. is a public company that has been in the industry for 11 years. The company currently specializes in the Biotechnology, Pharmaceuticals areas. The position of the Co-Founder & CEO is occupied by Chandler D. Robinson. Its headquarters is located at Wilmette, Illinois, USA. The number of employees ranges from 1 to 25. The Monopar Therapeutics Inc. annual revenue is estimated at < 1M. Total funding of the company - $20.7M. To connect with Monopar Therapeutics Inc. employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
10-50 employees
SIC Code
2834
DMA Code
Chicago Metropolitan Area
Founded
2015
Operating Status
Independent Company
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2014 | Partnership | 250 - 500 | < 1M | $676M | |
| 2023 | Public Company | 1 - 25 | 7.3M | $204.2M | |
| 2008 | Public Company | 100 - 250 | 66.4M | $290.6M | |
| 2001 | Public Company | 25 - 100 | 13.2M | $165.2M | |
| 2008 | Public Company | 500 - 1.0K | 157.5M | $226M | |
| 2011 | Public Company | 1.0K - 5.0K | 588.9M | $1.3B | |
| 2016 | Privately Held | 25 - 100 | < 1M | $463M | |
| 2000 | Public Company | 100 - 250 | 38.4M | $361.3M | |
| 2001 | Public Company | 1 - 25 | 4.6M | $141.4M | |
| 1948 | Public Company | 10K - 50K | 16B | $31.1M | |
| 1994 | Public Company | 500 - 1.0K | 1.2B | $118.3M | |
| 2016 | - | 100 - 250 | 3M | $263M | |
| 2007 | Privately Held | 500-1000 | < 1M | $797.7M | |
| 2018 | Privately Held | 100-200 | < 1M | $415M | |
| 1990 | - | 100-200 | - | $- | |
| 2010 | - | - | $- | ||
| 2010 | - | 100-200 | - | $- | |
| 2006 | - | 10-50 | - | $- | |
| - | - | 1000-5000 | - | $- | |
| - | - | 500-1000 | - | $- |
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Current employees switched from
Length of Employment
Employee tenure at Monopar Therapeutics Inc. shows a diverse range of experience levels:
7% have been with the company for less than 1 year29% for 1–2 years21% for 3–4 years21% for 5–7 years21% for 8–10 yearsEx-employees positions
In Company
In New Company
Contact top employees from
Monopar Therapeutics Inc.
Holli Herbert Carlson
Director, Clinical Operations
Jessica Merkle
Accounting Associate
Kim Tsuchimoto
Chief Financial Officer
Andrew Cittadine
Chief Operating Officer
Eric Kawamoto
Senior Scientist
Aidan Kelly
Program Management Associate
Zane Goodwin
Strategy & Operations
Veera Anand
Intern
Declan Tuffy
Senior Manager, Clinical Science
Heather Erskine
Executive Director, Patient Affairs and Market Access
Maria Charisi
Project Management Associate
Meagan Knox
Clinical Project Coordinator
Eunkyung Lee
CMC Operations Associate
Chandler Robinson
Chief Executive Officer
Similar Companies
FAQ
Monopar Therapeutics Inc. operates in the Biotechnology industries. More details can be found on the official website: monopartx.com.
The headquarters of Monopar Therapeutics Inc. are located in Wilmette, United States.
The current CEO of Monopar Therapeutics Inc. is Chandler D. Robinson
You can contact Monopar Therapeutics Inc. by phone at (847) 388-0349.
Monopar Therapeutics Inc. currently employs 10-50 people.
Monopar Therapeutics Inc.'s revenue is approximately < 1M.
Well-known competitors of Monopar Therapeutics Inc. include CARsgen Therapeutics, CervoMed, CytomX Therapeutics and Five Prime Therapeutics, Inc..
